Cargando…
Describing the hexapeptide identity platform between the influenza A H5N1 and Homo sapiens proteomes
We searched the primary sequence of influenza A H5N1 polyprotein for hexamer amino acid sequences shared with human proteins using the Protein International Resource database and the exact peptide matching analysis program. We find that the viral polyprotein shares numerous hexapeptides with the hum...
Autor principal: | |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2943197/ https://www.ncbi.nlm.nih.gov/pubmed/20859452 |
_version_ | 1782187010653421568 |
---|---|
author | Kanduc, Darja |
author_facet | Kanduc, Darja |
author_sort | Kanduc, Darja |
collection | PubMed |
description | We searched the primary sequence of influenza A H5N1 polyprotein for hexamer amino acid sequences shared with human proteins using the Protein International Resource database and the exact peptide matching analysis program. We find that the viral polyprotein shares numerous hexapeptides with the human proteome. The human proteins involved in the viral overlap are represented by antigens associated with basic cell functions such as proliferation, development, and differentiation. Of special importance, many human proteins that share peptide sequences with influenza A polyprotein are antigens such as reelin, neurexin I-α, myosin-IXa, Bardet–Biedl syndrome 10 protein, Williams syndrome transcription factor, disrupted in schizophrenia 1 protein, amyotrophic lateral sclerosis 2 chromosomal region candidate gene 17 protein, fragile X mental retardation 2 protein, and jouberin. That is, the viral-vs-human overlap involves human proteins that, when altered, have been reported to be potentially associated with multiple neurological disorders that can include autism, epilepsy, obesity, dystonia, ataxia–telangiectasia, amyotrophic lateral sclerosis, sensorineural deafness, sudden infant death syndrome, Charcot-Marie-Tooth disease, and myelination. The present data are discussed as a possible molecular basis for understanding influenza A viral escape from immunosurveillance and for defining anti-influenza immune-therapeutic approaches devoid of collateral adverse events. |
format | Text |
id | pubmed-2943197 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2010 |
publisher | Dove Medical Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-29431972010-09-21 Describing the hexapeptide identity platform between the influenza A H5N1 and Homo sapiens proteomes Kanduc, Darja Biologics Original Research We searched the primary sequence of influenza A H5N1 polyprotein for hexamer amino acid sequences shared with human proteins using the Protein International Resource database and the exact peptide matching analysis program. We find that the viral polyprotein shares numerous hexapeptides with the human proteome. The human proteins involved in the viral overlap are represented by antigens associated with basic cell functions such as proliferation, development, and differentiation. Of special importance, many human proteins that share peptide sequences with influenza A polyprotein are antigens such as reelin, neurexin I-α, myosin-IXa, Bardet–Biedl syndrome 10 protein, Williams syndrome transcription factor, disrupted in schizophrenia 1 protein, amyotrophic lateral sclerosis 2 chromosomal region candidate gene 17 protein, fragile X mental retardation 2 protein, and jouberin. That is, the viral-vs-human overlap involves human proteins that, when altered, have been reported to be potentially associated with multiple neurological disorders that can include autism, epilepsy, obesity, dystonia, ataxia–telangiectasia, amyotrophic lateral sclerosis, sensorineural deafness, sudden infant death syndrome, Charcot-Marie-Tooth disease, and myelination. The present data are discussed as a possible molecular basis for understanding influenza A viral escape from immunosurveillance and for defining anti-influenza immune-therapeutic approaches devoid of collateral adverse events. Dove Medical Press 2010 2010-09-13 /pmc/articles/PMC2943197/ /pubmed/20859452 Text en © 2010 Kanduc, publisher and licensee Dove Medical Press Ltd. This is an Open Access article which permits unrestricted noncommercial use, provided the original work is properly cited. |
spellingShingle | Original Research Kanduc, Darja Describing the hexapeptide identity platform between the influenza A H5N1 and Homo sapiens proteomes |
title | Describing the hexapeptide identity platform between the influenza A H5N1 and Homo sapiens proteomes |
title_full | Describing the hexapeptide identity platform between the influenza A H5N1 and Homo sapiens proteomes |
title_fullStr | Describing the hexapeptide identity platform between the influenza A H5N1 and Homo sapiens proteomes |
title_full_unstemmed | Describing the hexapeptide identity platform between the influenza A H5N1 and Homo sapiens proteomes |
title_short | Describing the hexapeptide identity platform between the influenza A H5N1 and Homo sapiens proteomes |
title_sort | describing the hexapeptide identity platform between the influenza a h5n1 and homo sapiens proteomes |
topic | Original Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2943197/ https://www.ncbi.nlm.nih.gov/pubmed/20859452 |
work_keys_str_mv | AT kanducdarja describingthehexapeptideidentityplatformbetweentheinfluenzaah5n1andhomosapiensproteomes |